Since meningitis is a very dangerous infectious disease affecting the meninges and is especially severe in children, you can protect your child by vaccinating them. It can help protect against several of the most common types of the disease, but it is not recommended for everyone and not in all cases.
This vaccine was developed in America and is made using a special method—by binding antigens to proteins, which helps the body better respond and remember the immune system. It works against four types of meningococci: groups A, C, W, and Y. After receiving the Menactra vaccine, approximately nine out of ten people achieve strong immunity. Side effects are almost nonexistent, except for mild redness of the skin where the vaccine was injected and sometimes a slight fever.
It was developed by British scientists using genetically modified technologies. This vaccine targets exclusively the most insidious group of meningococci—serogroup B. Its effectiveness is slightly lower than that of Menactra—seven to eight out of ten people are successfully protected. However, Bexero stimulates local immunity much more actively, causing mild inflammation and pain at the injection site.
Another American development, created using a similar technology to Bexero. It also targets group B meningococci, but is administered to adolescents over ten years of age, with only two doses. The effect is good—eight out of ten people are reliably protected. Just like Bexero, this vaccine can cause slight discomfort at the injection site, but the discomfort wears off quickly and is well tolerated.
Meningococcal vaccinations are available at specialized private medical institutions, such as the K+31 clinic, where patients are offered high-quality vaccines.
The standard vaccination schedule depends on the child's age and the type of vaccine used:
| Age | Vaccine type | Features |
|---|---|---|
| From 2 months | Conjugate meningococcal vaccines (such as MenACWY) | 2-3 injections 1-2 months apart, then a booster dose after reaching 1 year of age. |
| Over 1 year | Single injection (e.g., MenACWY or MenB) | Immunity lasts for 3 to 5 years; booster shots are possible later. |
| Adolescents | One shot (recommended before visiting crowded places) | Protects the child against all major bacterial groups: A, C, W, Y, and B. |
The first dose of meningococcal vaccine can be given to children as young as nine months old if there is a high risk of contracting the disease. However, full, lasting immunity is only developed after a full course of vaccinations, so most doctors recommend starting the full program closer to age two.
As for the timing and method of vaccination, a person's age determines a lot:
During an epidemic surge in infection, additional vaccination is mandatory for patients who received their previous vaccination more than four years ago, as well as for those who were vaccinated for the first time or have never been vaccinated before.
Before heading out for a meningitis vaccination, make sure your child is completely healthy and ready for this important event. To ensure everything goes smoothly, here's what to do in advance:
It's important to remember: advance preparation will ensure safety and peace of mind for both you and your child. The more carefully you follow all your doctor's recommendations, the fewer risks will arise later.
This award is given to clinics with the highest ratings according to user ratings, a large number of requests from this site, and in the absence of critical violations.
This award is given to clinics with the highest ratings according to user ratings. It means that the place is known, loved, and definitely worth visiting.
The ProDoctors portal collected 500 thousand reviews, compiled a rating of doctors based on them and awarded the best. We are proud that our doctors are among those awarded.
Экстренная помощь
General information about meningococcal infection
Meningococcal disease, commonly known as meningitis, is a serious infection caused by the microorganism Neisseria meningitidis. Transmission of the pathogen occurs primarily through aerosols and direct contact with an infected person or carrier, including close contact such as kissing, coughing, or sneezing.
Among the most dangerous manifestations of the disease are meningeal disease and meningococcal sepsis. The former is characterized by involvement of the meninges and spine, while the latter is characterized by the spread of bacteria through the bloodstream.
These conditions pose a significant health risk and can lead to death in just a few hours. A vaccine against meningococcal disease is effective in preventing severe disease and minimizing the risk of serious complications.